(Q43634509)

25 November 2017

Safe administration of irinotecan, oxaliplatin and raltitrexed in a DPD-deficient patient with metastatic colon cancer (English)

1 reference

25 November 2017

1 reference

1 reference

J Volk

1

1 reference

25 November 2017

F Reinke

2

1 reference

25 November 2017

A B van Kuilenburg

3

1 reference

25 November 2017

A H van Gennip

4

1 reference

25 November 2017

C Schlichting

5

1 reference

25 November 2017

A Ganser

6

1 reference

25 November 2017

P Schöffski

7

1 reference

25 November 2017

1 April 2001

1 reference

25 November 2017

1 reference

25 November 2017

12

1 reference

25 November 2017

4

1 reference

25 November 2017

569-571

1 reference

Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome

25 November 2017

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011178111295

7 January 2021

Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011178111295

7 January 2021

Oxaliplatin: a review of preclinical and clinical studies.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011178111295

7 January 2021

Mature results from three large controlled studies with raltitrexed ('Tomudex').

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011178111295

7 January 2021

Lack of correlation between phenotype and genotype for the polymorphically expressed dihydropyrimidine dehydrogenase in a family of Pakistani origin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011178111295

7 January 2021

Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011178111295

7 January 2021

Irinotecan. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011178111295

7 January 2021

Chemotherapy for the treatment of patients with metastatic colorectal cancer: an overview

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011178111295

7 January 2021

Identifiers

DOI

10.1023/A:1011178111295

1 reference

25 November 2017

1 reference